We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
Heidi C. Lew, PharmD
Advertisement
Articles by Heidi C. Lew, PharmD
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
Advertisement
Latest Updated Articles
- Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate
September 16th 2013
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5